TIDMGSK
RNS Number : 4137F
GlaxoSmithKline PLC
20 February 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Ms E Walmsley
=== ====================== ======================================
b) Position/status Chief Executive Officer
=== ====================== ======================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============ ====================
GBP0.0000 12,482 (Deferred)
=== ====================== ============ ====================
GBP0.0000 8,614 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 21,096
volume Price GBP0.0000
=== ====================== ======================================
e) Date of the 2018-02-16
transaction
=== ====================== ======================================
f) Place of the n/a
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==================================================================
a) Name Ms E Walmsley
=== ====================== ==========================================
b) Position/status Chief Executive Officer
=== ====================== ==========================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ==========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==================================================================
a) Name GlaxoSmithKline plc
=== ====================== ==========================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ==========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ==========================================
b) Nature of The sale of Ordinary Shares
the transaction to meet tax liabilities on nil-cost
options over Ordinary Shares
exercised on 16 February 2018
under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ====================== ==========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== =============== =====================
GBP13.1563 5,868 (Deferred)
=== ====================== =============== =====================
GBP13.1563 4,050 (Matching)
=============== =====================
d) Aggregated
information
===
Aggregated 9,918
volume Price GBP13.1563
=== ====================== ==========================================
e) Date of the 2018-02-16
transaction
=== ====================== ==========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ==========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===============================================================
a) Name Mr R Connor
=== ======================= ======================================
b) Position/status President, Global Manufacturing
& Supply
=== ======================= ======================================
c) Initial notification/ Initial Notification
amendment
=== ======================= ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===============================================================
a) Name GlaxoSmithKline plc
=== ======================= ======================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ======================= ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============ ====================
GBP0.0000 9,142 (Deferred)
=== ======================= ============ ====================
GBP0.0000 6,308 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 15,450
volume Price GBP0.0000
=== ======================= ======================================
e) Date of the 2018-02-16
transaction
=== ======================= ======================================
f) Place of the n/a
transaction
=== ======================= ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =================================================================
a) Name Mr R Connor
=== ======================= ========================================
b) Position/status President, Global Manufacturing
& Supply
=== ======================= ========================================
c) Initial notification/ Initial Notification
amendment
=== ======================= ========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =================================================================
a) Name GlaxoSmithKline plc
=== ======================= ========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= ========================================
b) Nature of the The sale of Ordinary Shares
transaction to meet tax liabilities on
nil-cost options over Ordinary
Shares exercised on 16 February
2018 under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ======================= ========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============== ====================
GBP13.1028 4,384 (Deferred)
=== ======================= ============== ====================
GBP13.1200 3,026 (Matching)
============== ====================
d) Aggregated information
===
Aggregated volume 7,410
Price GBP13.1114
=== ======================= ========================================
e) Date of the 2018-02-16
transaction
=== ======================= ========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================= ========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr S Dingemans
=== ====================== ======================================
b) Position/status Chief Financial Officer
=== ====================== ======================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============ ====================
GBP0.0000 17,435 (Deferred)
=== ====================== ============ ====================
GBP0.0000 12,030 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 29,465
volume Price GBP0.0000
=== ====================== ======================================
e) Date of the 2018-02-16
transaction
=== ====================== ======================================
f) Place of the n/a
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =================================================================
a) Name Mr S Dingemans
=== ======================= ========================================
b) Position/status Chief Financial Officer
=== ======================= ========================================
c) Initial notification/ Initial Notification
amendment
=== ======================= ========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =================================================================
a) Name GlaxoSmithKline plc
=== ======================= ========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= ========================================
b) Nature of the The sale of Ordinary Shares
transaction to meet tax liabilities on
nil-cost options over Ordinary
Shares exercised on 16 February
2018 under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ======================= ========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============== ====================
GBP13.1236 8,360 (Deferred)
=== ======================= ============== ====================
GBP13.1230 5,768 (Matching)
============== ====================
d) Aggregated information
===
Aggregated volume 14,128
Price GBP13.1233
=== ======================= ========================================
e) Date of the 2018-02-16
transaction
=== ======================= ========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================= ========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ================================================================
a) Name Mr N Hirons
=== ======================= =======================================
b) Position/status SVP, Global Ethics and Compliance
=== ======================= =======================================
c) Initial notification/ Initial Notification
amendment
=== ======================= =======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ================================================================
a) Name GlaxoSmithKline plc
=== ======================= =======================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= =======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= =======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ======================= =======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============= ====================
GBP0.0000 6,402 (Deferred)
=== ======================= ============= ====================
GBP0.0000 4,418 (Matching)
============= ====================
d) Aggregated
information
===
Aggregated 10,820
volume Price GBP0.0000
=== ======================= =======================================
e) Date of the 2018-02-16
transaction
=== ======================= =======================================
f) Place of the n/a
transaction
=== ======================= =======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =================================================================
a) Name Mr N Hirons
=== ======================= ========================================
b) Position/status SVP, Global Ethics and Compliance
=== ======================= ========================================
c) Initial notification/ Initial Notification
amendment
=== ======================= ========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =================================================================
a) Name GlaxoSmithKline plc
=== ======================= ========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= ========================================
b) Nature of the The sale of Ordinary Shares
transaction to meet tax liabilities on
nil-cost options over Ordinary
Shares exercised on 16 February
2018 under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ======================= ========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============== ====================
GBP13.1068 3,070 (Deferred)
=== ======================= ============== ====================
GBP13.1118 2,120 (Matching)
============== ====================
d) Aggregated information
===
Aggregated volume 5,190
Price GBP13.1093
=== ======================= ========================================
e) Date of the 2018-02-16
transaction
=== ======================= ========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================= ========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Mr D Redfern
=== ====================== ======================================
b) Position/status Chief Strategy Officer
=== ====================== ======================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============ ====================
GBP0.0000 10,258 (Deferred)
=== ====================== ============ ====================
GBP0.0000 7,078 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 17,336
volume Price GBP0.0000
=== ====================== ======================================
e) Date of the 2018-02-16
transaction
=== ====================== ======================================
f) Place of the n/a
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =================================================================
a) Name Mr D Redfern
=== ======================= ========================================
b) Position/status Chief Strategy Officer
=== ======================= ========================================
c) Initial notification/ Initial Notification
amendment
=== ======================= ========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =================================================================
a) Name GlaxoSmithKline plc
=== ======================= ========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= ========================================
b) Nature of the The sale of Ordinary Shares
transaction to meet tax liabilities on
nil-cost options over Ordinary
Shares exercised on 16 February
2018 under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ======================= ========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============== ====================
GBP13.1800 4,822 (Deferred)
=== ======================= ============== ====================
GBP13.1800 3,328 (Matching)
============== ====================
d) Aggregated information
===
Aggregated volume 8,150
Price GBP13.1800
=== ======================= ========================================
e) Date of the 2018-02-16
transaction
=== ======================= ========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================= ========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Ms C Thomas
=== ====================== ======================================
b) Position/status SVP, Human Resources
=== ====================== ======================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============ ====================
GBP0.0000 13,805 (Deferred)
=== ====================== ============ ====================
GBP0.0000 9,525 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 23,330
volume Price GBP0.0000
=== ====================== ======================================
e) Date of the 2018-02-16
transaction
=== ====================== ======================================
f) Place of the n/a
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ================================================================
a) Name Ms C Thomas
=== ====================== ========================================
b) Position/status SVP, Human Resources
=== ====================== ========================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ================================================================
a) Name GlaxoSmithKline plc
=== ====================== ========================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ========================================
b) Nature of the The sale of Ordinary Shares
transaction to meet tax liabilities on
nil-cost options over Ordinary
Shares exercised on 16 February
2018 under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ====================== ========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============== ====================
GBP13.1180 6,489 (Deferred)
=== ====================== ============== ====================
GBP13.1180 4,478 (Matching)
============== ====================
d) Aggregated
information
===
Aggregated 10,967
volume Price GBP13.1180
=== ====================== ========================================
e) Date of the 2018-02-16
transaction
=== ====================== ========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===============================================================
a) Name Mr P Thomson
=== ======================= ======================================
b) Position/status President, Global Affairs
=== ======================= ======================================
c) Initial notification/ Initial Notification
amendment
=== ======================= ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===============================================================
a) Name GlaxoSmithKline plc
=== ======================= ======================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ======================= ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ======================= ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ======================= ============ ====================
GBP0.0000 4,689 (Deferred)
=== ======================= ============ ====================
GBP0.0000 3,235 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 7,924
volume Price GBP0.0000
=== ======================= ======================================
e) Date of the 2018-02-19
transaction
=== ======================= ======================================
f) Place of the n/a
transaction
=== ======================= ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ================================================================
a) Name Mr P Thomson
=== ====================== ========================================
b) Position/status President, Global Affairs
=== ====================== ========================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ================================================================
a) Name GlaxoSmithKline plc
=== ====================== ========================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ========================================
b) Nature of the The sale of Ordinary Shares
transaction to meet tax liabilities on
nil-cost options over Ordinary
Shares exercised on 19 February
2018 under the Company's Deferred
Annual Bonus Plan - Deferred
Bonus and Matching Awards.
=== ====================== ========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============== ====================
GBP13.1240 2,204 (Deferred)
=== ====================== ============== ====================
GBP13.1240 1,521 (Matching)
============== ====================
d) Aggregated
information
===
Aggregated 3,725
volume Price GBP13.1240
=== ====================== ========================================
e) Date of the 2018-02-19
transaction
=== ====================== ========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ========================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ==============================================================
a) Name Dr P Vallance
=== ====================== ======================================
b) Position/status Outgoing President, R&D
=== ====================== ======================================
c) Initial notification/ Initial Notification
amendment
=== ====================== ======================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ==============================================================
a) Name GlaxoSmithKline plc
=== ====================== ======================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ======================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ==============================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== ======================================
b) Nature of The exercise of nil-cost options
the transaction over Ordinary Shares granted
on 11 February 2015 under the
Company's 2009 Deferred Annual
Bonus Plan - Deferred Bonus
and Matching Awards.
=== ====================== ======================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============ ====================
GBP0.0000 20,322 (Deferred)
=== ====================== ============ ====================
GBP0.0000 14,022 (Matching)
============ ====================
d) Aggregated
information
===
Aggregated 34,344
volume Price GBP0.0000
=== ====================== ======================================
e) Date of the 2018-02-19
transaction
=== ====================== ======================================
f) Place of the n/a
transaction
=== ====================== ======================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== =================================================================
a) Name Dr P Vallance
=== ====================== =========================================
b) Position/status Outgoing President, R&D
=== ====================== =========================================
c) Initial notification/ Initial Notification
amendment
=== ====================== =========================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== =================================================================
a) Name GlaxoSmithKline plc
=== ====================== =========================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== =========================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== =================================================================
a) Description Ordinary shares of 25 pence
of the financial each ('Ordinary Shares')
instrument
ISIN: GB0009252882
=== ====================== =========================================
b) Nature of the The sale of Ordinary Shares
transaction following the exercise of options
on 19 February 2018 under the
Company's Deferred Annual Bonus
Plan - Deferred Bonus and Matching
Awards.
=== ====================== =========================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ====================== ============== =====================
GBP13.1760 20,322 (Deferred)
=== ====================== ============== =====================
GBP13.1760 14,022 (Matching)
============== =====================
d) Aggregated
information
===
Aggregated 34,344
volume Price GBP13.1180
=== ====================== =========================================
e) Date of the 2018-02-19
transaction
=== ====================== =========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== =========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXBLFLVLFFBBL
(END) Dow Jones Newswires
February 20, 2018 08:15 ET (13:15 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
